Baird Medical Investment Holdings Ltd (BDMD) research
Baird Medical Investment Holdings Ltd- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $1.05
- As of
Baird Medical Investment Holdings Ltd (BDMD): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-03.
As of . Source: SEC EDGAR filings for BDMD. Method and limitations.
Share the BDMD intelligence card
See BDMD live in the terminal
Track BDMD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live BDMD terminal, freeActive signals for BDMD
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in BDMD
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 51% of BDMD (2026Q2)
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in BDMD
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 51% of BDMD (2026Q2)
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in BDMD
FREE, NO ACCOUNT
Every signal on BDMD, as it fires
You are seeing 5 of 7 signals recorded on BDMD since 2026-08-16.
The five above landed across 2 days. The other 2 were recorded on those same days. 7 of the 7 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in BDMD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP G0705H103 · 2026Q2 | $64K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP G0705H103 · 2026Q2 | $64K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP G0705H103 · 2026Q2 | $63K | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP G0705H111 · 2026Q2 | $6K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, BDMD
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
BDMD against its peers
BDMD's operating margin of -113.7% ranks in the 48th percentile of 23 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | BDMD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 22.5M USD | 18.9M USD | 56 | 23 |
| Revenue YoY | -39.2% | n/a | n/a | 3 |
| Gross margin | 83.8% | 49.1% | 93 | 20 |
| Operating margin | -113.7% | -55.8% | 48 | 23 |
| Net margin | -121.0% | -48.4% | 40 | 23 |
| Return on equity | -87.0% | -88.4% | 52 | 21 |
Peers (24): SNWV, ELUT, NSPR, QTI, NSYS, PAVM, ARAY, TELA, FOFA, XTNT, PETV, RDGL, MDAI, GTHP, MYO, SRTS, COCH, MDNC, NNOX, POSC, MODD, RPID, OM, CTSO. Left out: TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BDMD: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more BDMD signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to BDMDand get the insider, 13F, options, and confluence read in one view.